Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank 薬物名(臨床試験情報から抽出) KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Tobramycin 💬
(TOBI PODHALER)
1件: Tobramycin (Tobi Podhaler)9件: Bethkis; TOBI; TOBI PODHALER; TOBRAMICINA; TOBRAMYCIN; Tobramycin inhalation solution; TOBRAMYCIN SULFATE; Tobramycine; Tobramycinum; --1件: 299 💬
2 Calcium lactate 💬
(Prequist powder (TN))
1件: Calcium lactate (Calcium Lactate Powder)1件: Calcium lactate; --1件: 235 💬
3 Polaprezinc 💬 1件: Polaprezinc1件: Polaprezinc; --2件: 96, 97 💬
4 Polidocanol 💬 1件: Polidocanol1件: Polidocanol; --1件: 279 💬
5 Potassium carbonate 💬 1件: Potassium carbonate0件: ---
6 Posaconazole 💬 1件: Posaconazole2件: Noxafil; POSACONAZOLE; --3件: 60, 65, 299 💬
7 Acacia 💬
(Powdered acacia (JP18))
1件: Acacia (Acacia powder)1件: Gum Arabic; --1件: 46 💬
8 Polyethylene glycol 3350 💬 1件: Polyethylene glycol4件: Macrogol; Macrogol 4000; Polyethylene glycol; Polyethylene Glycol 3350; --7件: 6, 78, 96, 97, 235, 276, 299 💬
9 Glycyrrhiza 💬
(Powdered glycyrrhiza (JP18))
1件: Licorice2件: Licorice; Liquorice; --2件: 53, 83 💬
10 Meningococcal polysaccharide vaccine group A 💬 1件: Meningococcal polysaccharide vaccine group A2件: Menveo; Nimenrix; --7件: 11, 13, 50, 61, 62, 66, 222 💬
11 Meningococcal polysaccharide vaccine group C 💬 1件: Meningococcal polysaccharide vaccine group C2件: Menveo; Nimenrix; --7件: 11, 13, 50, 61, 62, 66, 222 💬
12 Ginger 💬
(Powdered ginger (JP18))
1件: Ginger1件: Ginger; --2件: 46, 271 💬
13 Senna leaf 💬
(Powdered senna leaf (JP18))
1件: Senna leaf (Prodiem Plus Powder)1件: Senna; --1件: 291 💬
14 Ginseng 💬
(Powdered ginseng (JP18))
1件: Ginseng (Ginsamin Power)1件: Ginseng; --3件: 13, 46, 53 💬
15 Bupivacaine 💬
(POSIMIR)
1件: Bupivacaine (Posimir)2件: Bupivacaine; BUPIVACAINE HYDROCHLORIDE; 5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬8件: 46, 51, 53, 70, 96, 168, 226, 298 💬
16 Fenfluramine 💬
(Ponderax (TN))
1件: Fenfluramine (Pondimin Tab 20mg)2件: Fenfluramina; FENFLURAMINE; 5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬
10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬4件: 140, 144, 145, 149 💬
17 Hydroxychloroquine 💬
(Polirreumin (TN))
1件: Hydroxychloroquine3件: Hydroxychloroquine; Hydroxychloroquine Sulfate; PLAQUENIL; --27件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 💬
18 Poractant alfa 💬 1件: Poractant alfa1件: Curosurf; --1件: 211 💬
19 Potassium 💬 1件: Potassium1件: Potassium; --13件: 36, 46, 66, 67, 88, 93, 94, 98, 115, 167, 179, 215, 235 💬
20 Pomalidomide 💬 1件: Pomalidomide3件: Imnovid; Pomalidomida; Pomalidomide; 2件: IL6,
TNF 💬
80件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬5件: 28, 51, 85, 227, 331 💬
21 Ezogabine 💬
(Potiga (TN))
1件: Ezogabine (Potiga)4件: Ezogabine; Potiga; RETIGABINE; Trobalt; 5件: KCNQ1,
KCNQ2,
KCNQ3,
KCNQ4,
KCNQ5 💬
6件: Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬2件: 2, 144 💬
22 Mogamulizumab 💬
(Poteligeo (TN))
1件: Mogamulizumab (Poteligeo)1件: Mogamulizumab; 1件: CCR4 💬5件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Kaposi sarcoma-associated herpesvirus infection, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor 💬1件: 26 💬
23 Panax notoginseng root 💬
(Powdered panax notoginseng root (Non-JPS))
1件: Panax notoginseng root (Panax Notoginseng Root Powder)1件: Sanqi; --1件: 222 💬
24 Ponesimod 💬 1件: Ponesimod2件: PONESIMOD; Ponvory; 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
25 Pozelimab 💬 1件: Pozelimab1件: Pozelimab; 1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬2件: 11, 62 💬